SEC Comment Letter for GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416) (GALT) — Oct 8, 2010

GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)
Date: Oct. 8, 2010 · CIK: 0001133416 · Accession: 0000000000-10-059473

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-31791

Date

October 8, 2010

Author

Tabatha Akins

Form

UPLOAD

Company

GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)

Letter

October 8, 2010 Anthony D. Squeglia Chief Financial Officer Pro Pharmaceuticals, Inc. 7 Wells Avenue Newton, M A 02459

Re: Pro Pharmaceuticals, Inc. Form 8-K Filed September 30, 2010 File No. 001-31791

Dear Mr. Squeglia :

We have completed our review of your Form 8-K and have no further comments at this time.

Sincerely,
Tabatha Akins
Staff Accountant

Show Raw Text

October 8, 2010

Anthony D. Squeglia
Chief Financial Officer
Pro Pharmaceuticals, Inc.
7 Wells Avenue
Newton, M A 02459

Re: Pro Pharmaceuticals, Inc.
 Form 8-K
Filed September 30, 2010
File No. 001-31791

Dear Mr. Squeglia :

We have completed our review of your Form 8-K and have no further comments at this
time.

        Sincerely,

        Tabatha Akins
Staff Accountant

SecProbe.io